Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06702631 · ClinicalTrials.gov registry record · Early Phase 1

Nitrous Oxide Neuroimaging

A Early Phase 1 study of Pain and Anesthesia, sponsored by Keith M Vogt.

Recruiting
Registry status
Early Phase 1
Development phase
60
Enrollment target
1
Study location

NCT06702631 is a Early Phase 1 study of Pain and Anesthesia that is actively recruiting participants, run by Keith M Vogt. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06702631, a Early Phase 1 study of Pain and Anesthesia, is actively recruiting participants, sponsored by Keith M Vogt.

RECRUITING
Registry status
Early Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose nitrous oxide. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.

Interventions

  • DRUG Nitrous oxide
  • DEVICE Peripheral Nerve Stimulation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-01-13
Est. Completion 2026-06-01
Phase Early Phase 1

Sponsor

Keith M Vogt

7 total trials

What the Registry Record Tells You About NCT06702631

The ClinicalTrials.gov registry entry for NCT06702631 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The listed sponsor is Keith M Vogt, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Nitrous oxide is the first listed.

NCT06702631 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06702631 about?

NCT06702631 is a clinical study titled "Nitrous Oxide Neuroimaging". The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose nitrous oxide. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will...

What is the current status of trial NCT06702631?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2025-01-13. Estimated completion is 2026-06-01.

What conditions does trial NCT06702631 study?

This clinical trial studies the following conditions: Pain, Anesthesia, Amnesia.

What interventions are being tested in trial NCT06702631?

The interventions under investigation include: Nitrous oxide (DRUG), Peripheral Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06702631?

This trial is sponsored by Keith M Vogt, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06702631 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.